Botanix Pharmaceuticals Limited

ASX:BOT

Botanix Pharmaceuticals Limited

ASX:BOT
TradeAdd trade order Follow Unfollow Set Price Alert
$0.355 (-4.1%)
Last close price
#5
Rank
52
Held by
57
Followers
TradeAdd trade order Follow Unfollow Set Price Alert
Reports (2) My Report Forum Investors
Top member reports
Consensus
Remorhaz
Company Report
Last edited 5 months ago
PerformanceCommunity EngagementCommunity Endorsement
ranked
#106
Performance (54m)
15.2% pa
Followed by
64
Follow Unfollow
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
Become a member
#ASX Announcements
Remorhaz
Added 5 months ago
View author's company report

Botanix adds Payer coverage representing ~65 million commercial lives


Ascent Health, the second largest Payer organisation in the US, will now cover Sofdra™ (sofpironium) topical gel, 12.45%. Ascent Health represents approximately 65 million (or nearly 40%) of US commercial lives.

The Ascent coverage adds to the existing Payer coverage and coverage actively being finalised with Payers. The Company will share updates as coverage is announced in coming months, before our Sales Professionals begin calling on dermatologists

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02880659-6A1237535


DISC: Held in RL & SM

#Small and Mid Cap conference
stale
Remorhaz
Added 6 months ago
View author's company report

Botanix CEO Dr Howie McKibbon's 20 minute presentation at the recent ASX Small and Mid-Cap Conference September 2024 is now available on Youtube

ASX Small and Mid-Cap Conference September 2024 | Botanix Pharmaceuticals Limited (ASX:BOT)